Rezpegaldesleukin Potentially Promising for Atopic Dermatitis
Following 16 weeks of rezpegaldesleukin treatment in the REZOLVE-AD study, primary and key secondary end points have been met.
Dermocosmetics as Adjunctive Therapy Reduces Sensitivity and Improves Quality of Life in Acne
Dermocosmetics alongside traditional acne treatments improved skin tolerance and reduced acne severity in patients, particularly those using retinoids, leading to enhanced quality of life.
